Liquid chromatography mass spectrometry‐based O‐glycomics to evaluate glycosylation alterations in gastric cancer
Authors:
- 10 August 2015
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 10 (2) , 206-215
Abstract
Purpose: Gastric cancer is the fourth most common malignant cancer worldwide. Important for tumorigenesis and progression, aberrant glycosylation occurs frequently in cancers. We investigated the differences in O‐glycosylation in the serum of 157 gastric cancer patients (GC) and 144 healthy donors.Experimental design: We used the method of labeling O‐glycans (released from proteins) with 1‐phenyl‐3‐methyl‐5‐pyrazolone followed by LC‐MS analysis. Analyzing the LC‐MS data by partial least squares discriminant and unpaired Student t test, combined with the structural information of O‐glycans from LC‐MS/MS in positive mode.Results: The expression level of core1, core2, ST antigen, and core2 complex O‐glycans (m/z 733.33, m/z 809.42) were increased significantly (p < 0.0001), whereas m/z 529.75 and diST‐antigen were decreased in the serum of GC compared with controls (p < 0.001). In addition, there were significant correlations between the abundance of the O‐glycans and glycoproteins (MUC1, CEA) in the serum of GC.Conclusion and clinical relevance: Glycomics approaches identified multiple candidate antigens for patients with GC. The O‐glycan structures are increased in the serum of GC, they may be candidates for carbohydrate tumor markers.Keywords
Funding Information
- National Science and Technology key projects during the Twelfth Five-Year Plan Period of China (2012ZX09401-014, 2012ZX09502001-001, 2012CB822100)
- Program for Changjiang Scholars and Innovative Research Team in University (IRT1075)
- Natural Science Foundation of Jiangsu Province (BK20140370)
This publication has 43 references indexed in Scilit:
- Developments in the Identification of Glycan Biomarkers for the Detection of CancerMolecular & Cellular Proteomics, 2013
- N-glycosylation of Colorectal Cancer TissuesMolecular & Cellular Proteomics, 2012
- Two opposing roles of O-glycans in tumor metastasisTrends in Molecular Medicine, 2012
- Tumour-associated carbohydrate antigens in breast cancerBreast Cancer Research, 2010
- Glycomics and disease markersCurrent Opinion in Chemical Biology, 2009
- Core3 O-Glycan Synthase Suppresses Tumor Formation and Metastasis of Prostate Carcinoma PC3 and LNCaP Cells through Down-regulation of α2β1 Integrin ComplexJournal of Biological Chemistry, 2009
- The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serumGlycobiology, 2008
- C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cellsOncogene, 2006
- Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profilesGlycobiology, 2005
- Multiple Forms of Mammalian Sialidase. Altered Expression in Carcinogenesis.The Tohoku Journal of Experimental Medicine, 1992